Page last updated: 2024-12-07
4-cyclohexylaniline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-cyclohexylaniline: analgesic activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 80764 |
CHEMBL ID | 4780820 |
SCHEMBL ID | 112829 |
MeSH ID | M0090884 |
Synonyms (32)
Synonym |
---|
STL353499 |
einecs 228-918-9 |
4-cyclohexylphenylamine |
6373-50-8 |
aniline, p-cyclohexyl- |
benzenamine, 4-cyclohexyl- |
4-cyclohexylaniline |
p-cyclohexylaniline, hydrobromide |
inchi=1/c12h17n/c13-12-8-6-11(7-9-12)10-4-2-1-3-5-10/h6-10h,1-5,13h |
AKOS000100590 |
A834491 |
FT-0618318 |
BBL023570 |
BP-21493 |
SCHEMBL112829 |
p-cyclohexylphenylamine |
4-cyclohexyl-phenylamine |
p-cyclohexylaniline |
p-cyclohexylphenyl amine |
4-cyclohexylanilin |
4-cyclohexyl-aniline |
4-cyclohexyl phenylamine |
4-cyclohexylbenzenamine |
CS-W017440 |
PS-8599 |
DTXSID60213154 |
mfcd00001454 |
(4-cyclohexylphenyl)amine |
SY106471 |
H10453 |
CHEMBL4780820 |
EN300-200103 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1724069 | Antimycobacterial activity against Mycobacterium tuberculosis H37Rv | 2020 | Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18 | Uridine natural products: Challenging targets and inspiration for novel small molecule inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.41) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |